Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat

Saved in:
Bibliographic Details
Main Authors: Shohei Sakata, Yasuko Mera, Yukiharu Kuroki, Reiko Nashida, Makoto Kakutani, Takeshi Ohta
Format: Article
Language:English
Published: Wiley 2014-01-01
Series:Journal of Diabetes Research
Online Access:http://dx.doi.org/10.1155/2014/890639
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832561977354878976
author Shohei Sakata
Yasuko Mera
Yukiharu Kuroki
Reiko Nashida
Makoto Kakutani
Takeshi Ohta
author_facet Shohei Sakata
Yasuko Mera
Yukiharu Kuroki
Reiko Nashida
Makoto Kakutani
Takeshi Ohta
author_sort Shohei Sakata
collection DOAJ
format Article
id doaj-art-637ebc5a28e044b09ad925f3a5b3f29b
institution Kabale University
issn 2314-6745
2314-6753
language English
publishDate 2014-01-01
publisher Wiley
record_format Article
series Journal of Diabetes Research
spelling doaj-art-637ebc5a28e044b09ad925f3a5b3f29b2025-02-03T01:23:45ZengWileyJournal of Diabetes Research2314-67452314-67532014-01-01201410.1155/2014/890639890639Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic RatShohei Sakata0Yasuko Mera1Yukiharu Kuroki2Reiko Nashida3Makoto Kakutani4Takeshi Ohta5Biological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, JapanBiological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, JapanBiological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, JapanBiological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, JapanBiological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, JapanBiological/Pharmacological Research Laboratories, Central Pharmaceutical Research Institute, Japan Tobacco Inc., 1-1 Murasaki-cho, Takatsuki, Osaka 569-1125, Japanhttp://dx.doi.org/10.1155/2014/890639
spellingShingle Shohei Sakata
Yasuko Mera
Yukiharu Kuroki
Reiko Nashida
Makoto Kakutani
Takeshi Ohta
Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
Journal of Diabetes Research
title Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
title_full Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
title_fullStr Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
title_full_unstemmed Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
title_short Combination Therapy of an Intestine-Specific Inhibitor of Microsomal Triglyceride Transfer Protein and Peroxisome Proliferator-Activated Receptor γ Agonist in Diabetic Rat
title_sort combination therapy of an intestine specific inhibitor of microsomal triglyceride transfer protein and peroxisome proliferator activated receptor γ agonist in diabetic rat
url http://dx.doi.org/10.1155/2014/890639
work_keys_str_mv AT shoheisakata combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat
AT yasukomera combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat
AT yukiharukuroki combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat
AT reikonashida combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat
AT makotokakutani combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat
AT takeshiohta combinationtherapyofanintestinespecificinhibitorofmicrosomaltriglyceridetransferproteinandperoxisomeproliferatoractivatedreceptorgagonistindiabeticrat